Everest Medicines Limited announced that Dr. Kerry Blanchard has resigned as a member of the Board of Directors, effective immediately. He will remain as an advisor to Everest for the six months following his resignation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.2 HKD | +1.14% | +0.45% | +6.22% |
05-14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
05-14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.22% | 900M | |
-0.28% | 90.59B | |
-0.92% | 38.99B | |
-9.57% | 34.09B | |
-17.98% | 15.02B | |
-6.74% | 13.17B | |
-9.76% | 11.88B | |
-47.31% | 10.65B | |
+7.27% | 9.25B | |
+137.06% | 9.02B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Limited Announces Resignation of Kerry Blanchard as A Member of the Board of Directors